Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Madsen

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Endocrinology|May 9, 2013
Circulating levels of pegvisomant and endogenous growth hormone during prolonged pegvisomant therapy in patients with acromegalyMichael Madsen, Sanne Fisker, Ulla Feldt-Rasmussen, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 14, 2012
Erythropoietin administration acutely stimulates resting energy expenditure in healthy young menBritt Christensen, Mikkel H Vendelbo, Thomas Krusenstjerna-Hafstrøm, et al.
Plos One|May 12, 2011
Insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose loadThomas Krusenstjerna-Hafstrøm, Michael Madsen, Mikkel H Vendelbo, et al.
Pediatric Nephrology (Berlin, Germany)|November 11, 2009
Effects of GH in human muscle and fatJens Otto Lunde Jørgensen, Kristine Z Rubeck, Thomas S Nielsen, et al.
European Journal of Endocrinology|June 3, 2015
GH signaling in human adipose and muscle tissue during 'feast and famine': amplification of exercise stimulation following fasting compared to glucose administrationMikkel H Vendelbo, Britt Christensen, Solbritt B Grønbæk, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2019
Fibroblast Activation Protein is a GH Target: A Prospective Study of Patients with Acromegaly Before and After TreatmentMai C Arlien-Søborg, Camilla Grøndahl, Amanda Bæk, et al.
The Journal of Clinical Endocrinology and Metabolism|November 19, 2010
Acute peripheral metabolic effects of intraarterial ghrelin infusion in healthy young menEsben Thyssen Vestergaard, Mads Buhl, Jakob Gjedsted, et al.
Emerging Infectious Diseases|March 11, 2021
Intersecting Paths of Emerging and Reemerging Infectious DiseasesTais M Wilson, Christopher D Paddock, Sarah Reagan-Steiner, et al.
Journal of Hazardous Materials|August 22, 2020
Impact of intermittent feeding on polishing of micropollutants by moving bed biofilm reactors (MBBR)Kai Tang, Peter Rosborg, Emma S Rasmussen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 3, 2012
Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a GH receptor antagonist: a randomized clinical trialMichael Madsen, Thomas Krusenstjerna-Hafstrøm, Louise Møller, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Endocrinology|May 9, 2013
Circulating levels of pegvisomant and endogenous growth hormone during prolonged pegvisomant therapy in patients with acromegalyMichael Madsen, Sanne Fisker, Ulla Feldt-Rasmussen, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|January 14, 2012
Erythropoietin administration acutely stimulates resting energy expenditure in healthy young menBritt Christensen, Mikkel H Vendelbo, Thomas Krusenstjerna-Hafstrøm, et al.
Plos One|May 12, 2011
Insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose loadThomas Krusenstjerna-Hafstrøm, Michael Madsen, Mikkel H Vendelbo, et al.
Pediatric Nephrology (Berlin, Germany)|November 11, 2009
Effects of GH in human muscle and fatJens Otto Lunde Jørgensen, Kristine Z Rubeck, Thomas S Nielsen, et al.
European Journal of Endocrinology|June 3, 2015
GH signaling in human adipose and muscle tissue during 'feast and famine': amplification of exercise stimulation following fasting compared to glucose administrationMikkel H Vendelbo, Britt Christensen, Solbritt B Grønbæk, et al.
The Journal of Clinical Endocrinology and Metabolism|September 24, 2019
Fibroblast Activation Protein is a GH Target: A Prospective Study of Patients with Acromegaly Before and After TreatmentMai C Arlien-Søborg, Camilla Grøndahl, Amanda Bæk, et al.
The Journal of Clinical Endocrinology and Metabolism|November 19, 2010
Acute peripheral metabolic effects of intraarterial ghrelin infusion in healthy young menEsben Thyssen Vestergaard, Mads Buhl, Jakob Gjedsted, et al.
Emerging Infectious Diseases|March 11, 2021
Intersecting Paths of Emerging and Reemerging Infectious DiseasesTais M Wilson, Christopher D Paddock, Sarah Reagan-Steiner, et al.
Journal of Hazardous Materials|August 22, 2020
Impact of intermittent feeding on polishing of micropollutants by moving bed biofilm reactors (MBBR)Kai Tang, Peter Rosborg, Emma S Rasmussen, et al.
The Journal of Clinical Endocrinology and Metabolism|February 3, 2012
Fat content in liver and skeletal muscle changes in a reciprocal manner in patients with acromegaly during combination therapy with a somatostatin analog and a GH receptor antagonist: a randomized clinical trialMichael Madsen, Thomas Krusenstjerna-Hafstrøm, Louise Møller, et al.
Pageof 3